<?xml-stylesheet type='text/xsl' href='ctgovTransform.xsl'?>
<CT.GOV_Trial requestNumber="2529">
  <stage>Registered</stage>
  <submitdate>13/10/2009</submitdate>
  <approvaldate>13/10/2009</approvaldate>
  <nctid>NCT00995124</nctid>
  <trial_identification>
    <studytitle>Trial of the Ovicidal Activity of Three Head Lice Products (NeutraLice Lotion®, NeutraLice Advance® and Moov Head Lice Solution®) After a Single Application</studytitle>
    <scientifictitle>A Randomised, Assessor Blind, Parallel Group, Comparative Trial of the Ovicidal Activity of Three Head Lice Products (NeutraLice Lotion®, NeutraLice Advance® and Moov Head Lice Solution®) After a Single Application</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>KEY/NL/003</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Head Lice</healthcondition>
    <conditioncode>
      <conditioncode1>Skin</conditioncode1>
      <conditioncode2>Other skin conditions</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Infection</conditioncode1>
      <conditioncode2>Other infectious diseases</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Infection</conditioncode1>
      <conditioncode2>Studies of infection and infectious agents</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Treatment: drugs - NeutraLice Lotion
Treatment: drugs - NeutraLice Advance Solution
Treatment: drugs - Moov Head Lice Solution

Experimental: NeutraLice Lotion - Single application of head lice product.

Experimental: NeutraLice Advance - single application of head lice product

Active Comparator: Moov Head Lice Solution - Single application for head lice with 10 min application time.


Treatment: drugs: NeutraLice Lotion
Head lice topical application to be applied once for 10 minutes.

Treatment: drugs: NeutraLice Advance Solution
head lice application to be applied once for 10 minutes

Treatment: drugs: Moov Head Lice Solution
Single application for head lice with 10 min application time.

</interventions>
    <comparator />
    <control />
    <interventioncode>Treatment: drugs</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Ovicidal efficacy index (OEI) The proportion of treated eggs hatched in-vitro divided by the proportion of pre-treated eggs hatched in-vitro expressed as a percentage up to and including 14 days after collection and incubation.</outcome>
      <timepoint>ovicidal activity assessed after 14 days</timepoint>
    </primaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>-  Male or female primary school-aged children.

          -  Presence of at least 20 live head lice eggs on the hair. The presence of live head
             lice eggs will be determined from a visual inspection of the hair.

          -  Parent / Guardian have given written informed consent to their child's participation
             in the trial.</inclusivecriteria>
    <inclusiveminage />
    <inclusiveminagetype>No limit</inclusiveminagetype>
    <inclusivemaxage>12</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>Yes</healthyvolunteer>
    <exclusivecriteria>-  History of allergies or adverse reactions to head lice products or the components of
             the specific products being tested.

          -  Treatment with any head lice product in the 4 weeks prior to participation in this
             trial.

          -  Treatment with hair dyes and bleaches within 4 weeks prior to participation in this
             trial.

          -  Presence of scalp disease(s).</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment />
    <sequence />
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3>The people assessing the outcomes</masking3>
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 4</phase>
    <anticipatedstartdate />
    <actualstartdate>1/10/2009</actualstartdate>
    <anticipatedenddate />
    <actualenddate />
    <samplesize>90</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Completed</recruitmentstatus>
    <anticipatedlastvisitdate />
    <actuallastvisitdate>1/12/2009</actuallastvisitdate>
    <dataanalysis />
    <withdrawnreason />
    <withdrawnreasonother />
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate>NSW</recruitmentstate>
    <hospital>Assoc. Prof. Stephen Barker - Brisbane</hospital>
    <postcode>4072 - Brisbane</postcode>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Commercial sector/Commercial sector/Industry</primarysponsortype>
    <primarysponsorname>Altman Biomedical Consulting Pty. Ltd.</primarysponsorname>
    <primarysponsoraddress />
    <primarysponsorcountry />
  </sponsorship>
  <ethicsAndSummary>
    <summary>The purpose of this study is to compare the ovicidal activity of three head lice treatment
      products.

      The study population will consist of Queensland primary school-aged children (Grades 1 - 7)
      who have at least 20 live eggs on the hair and who have not used any head lice product in the
      four weeks prior to the study.

      Enrollment will continue to achieve 30 subjects in each treatment group (total of 90
      subjects).</summary>
    <trialwebsite>https://clinicaltrials.gov/show/NCT00995124</trialwebsite>
    <publication />
    <ethicsreview />
    <publicnotes />
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Stephen Barker, PhD</name>
      <address>University of Queensland, Queensland, Australia</address>
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Public Queries</type>
    </contact>
  </contacts>
</CT.GOV_Trial>